(Q34431190)

2 August 2017

0 references

The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis (English)

1 reference

2 August 2017

0 references

1 reference

irritable bowel syndrome

1 reference

Alexander C Ford

0 references

Paul Moayyedi

0 references

Eamonn M M Quigley

1 reference

2 August 2017

Brian E Lacy

1 reference

2 August 2017

Anthony J Lembo

1 reference

2 August 2017

Yuri A Saito

1 reference

2 August 2017

Lawrence R Schiller

1 reference

2 August 2017

Edy E Soffer

1 reference

2 August 2017

Brennan M R Spiegel

1 reference

2 August 2017

language of work or name

English

0 references

publication date

29 July 2014

1 reference

The American Journal of Gastroenterology

2 August 2017

published in

1 reference

2 August 2017

volume

109

1 reference

2 August 2017

1 reference

2 August 2017

page(s)

1367-1374

1 reference

Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.195

An evidence-based position statement on the management of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.195

Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.195

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.195

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.195

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.195

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.195

Effects of linseeds on the symptoms of irritable bowel syndrome: a pilot randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.195

Wheat fibre and irritable bowel syndrome. A controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.195

Psyllium therapy in the irritable bowel syndrome. A double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.195

Comparison of the therapeutic effect of wheat bran, mebeverine and placebo in patients with the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.195

Is bran efficacious in irritable bowel syndrome? A double blind placebo controlled crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.195

Double blind study of ispaghula in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.195

Ispaghula therapy in irritable bowel syndrome: improvement in overall well-being is related to reduction in bowel dissatisfaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.195

Irritable bowel syndrome: Assessment of psychological disturbance and its influence on the response to fibre supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.195

Developing irritable bowel syndrome guidelines through meta-analyses: does the emperor really have new clothes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.195

Meta-analysis: Can we mix apples and oranges?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.195

Irritable bowel syndrome in primary care: the patients' and doctors' views on symptoms, etiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.195

Laxative properties of indigestible plastic particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.195

Clinical data support that psyllium is not fermented in the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.195

Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fas-mediated apoptosis of T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.195

Fiber and functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.195

Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.195

Mechanism of action of dietary fibre in the human colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.195

21 January 2018

Identifiers

DOI

10.1038/AJG.2014.195

1 reference

Dimensions Publication ID

2 August 2017

1009328873

0 references

Fatcat ID

release_synu7dzuifbc5gwn2bhp7uajo4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/synu7dzuifbc5gwn2bhp7uajo4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference